To determine the revascularization rate, clinical efficacy and safety of the CE-marked MindFrame System in ischemic stroke patients
To determine the revascularization rate, clinical efficacy and safety in a "real-world setting" of the CE-marked MindFrame System in ischemic stroke patients with thrombotic neurovascular occlusions caused by an embolus deemed appropriate for endovascular treatment. Target vessels include the basilar, internal carotid and middle cerebral (M1 and M2 segments) arteries.
- Mechanical Thrombectomy (Merci Retriever)Procedure
Other Names: RNA Sequencing Analysis Intervention Desc: Mechanical thrombectomy using a MindFrame device ARM 1: Kind: Experimental Label: Treatment Group Description: Subjects in whom a MindFrame Device was employed for restoration of flow and clot removal
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample
The purpose of this registry is to compile data in a "real world setting". All subjects in whom there is an attempt to use the device will be included in the registry. All subjects must be recruited according to the Mindframe System "Instructions For Use".
|Type||Measure||Time Frame||Safety Issue|
|Primary||Procedural Efficacy||Immediate postprocedure||No|
|Primary||Safety||90 days postprocedure||Yes|
|Primary||Clinical Efficacy||90 days postprocedure||No|
- MindFrame, Inc. Lead